Şefika Arzu Ergen

7PUBLICATIONS
48CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 06, 2026
Whole brain radiotherapy and simultaneous integrated boost: is it still a viable treatment for multiple brain metastases in the era of SRS?

Halil Cumhur Yıldırım, Nuri Kaydıhan, Ecem Demir

|Jan 27, 2026
Salvage radiotherapy in refractory adult Hodgkin and non-Hodgkin lymphoma.

Muhammed Veysel Hekim, Şefika Arzu Ergen, Tuğrul Elverdi

|Oct 24, 2025
Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study.

Şefika Arzu Ergen, Fazilet Öner Dinçbaş, Evrim Metcalfe

|Jul 01, 2024
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.

Arif Akyildiz, Melis Gultekin, Ecem Yigit

|Oct 03, 2022
Recurrence patterns of pancreatic cancer treated with adjuvant intensity modulated radiotherapy.

Halil Cumhur Yıldırım, Merve Şahin, Şefika Arzu Ergen

|Jan 04, 2021
Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.

Şefika Arzu Ergen, Ceren Barlas, Cumhur Yıldırım

Pageof 2

Frequent Collaborators

3 joint publications

Halil Cumhur Yıldırım

3 joint publications

Didem Çolpan Öksüz

2 joint publications

Fazilet Öner Dinçbaş

1 joint publications

Nuri Kaydıhan